Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNiguarda Hospital

About this trial

The purpose of this retrospective and prospective multicenter study is to evaluate the incidence of pulmonary hypertension (PH) within 6 months from ultrasound-assisted, Catheter-directed Thrombolysis for acute intermediate- high-risk Pulmonary Embolism

Eligibility criteria

Qualifiers

Patients admitted with acute intermediate-high risk PE, defined according to ESC guidelines

Symptoms onset within previous 14 days associated or not with deep venous thrombosis

Confirmation of the PE by contrast-enhanced computed tomography of the chest with embolus located in at least one main or proximal lower lobe pulmonary artery

Echocardiographic parameters of RV disfunction

Disqualifiers

Age < 18 years old

Patients unable to give informed consent

Pregnancy

Patients received fibrinolytic drugs in the preceding 4 days

Trial design

Treatments tested in this trial

  • ultrasound-assisted, catheter-directed thrombolysis

Treatment groups

180 Participants
are divided into 1 treatment group

Sponsors and collaborators